Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0000875320-26-000127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $480.31 | -2,329 | 37.7K | -6% | -$1.12M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | S | D | 2,329 | $480.31 | 37,734 | D | — | — |